Peter D. Kies

2023

In 2023, Peter D. Kies earned a total compensation of $1.2M as Chief Financial Officer at Inovio Pharmaceuticals, a 28% decrease compared to previous year.

Compensation breakdown

Non-Equity Incentive Plan$172,314
Option Awards$218,593
Salary$622,881
Stock Awards$132,252
Other$15,000
Total$1,161,040

Kies received $622.9K in salary, accounting for 54% of the total pay in 2023.

Kies also received $172.3K in non-equity incentive plan, $218.6K in option awards, $132.3K in stock awards and $15K in other compensation.

Rankings

In 2023, Peter D. Kies' compensation ranked 1,039th out of 2,918 executives tracked by ExecPay. In other words, Kies earned more than 64.4% of executives.

ClassificationRankingPercentile
All
1,039
out of 2,918
64th
Division
Manufacturing
622
out of 1,608
61st
Major group
Measuring, Analyzing, And Controlling Instruments; Photographic, Medical And Optical Goods; Watches And Clocks
73
out of 252
71st
Industry group
Surgical, Medical, And Dental Instruments And Supplies
46
out of 184
75th
Industry
Surgical and Medical Instruments and Apparatus
41
out of 144
72nd
Source: SEC filing on April 11, 2024.

Kies' colleagues

We found two more compensation records of executives who worked with Peter D. Kies at Inovio Pharmaceuticals in 2023.

2023

Jacqueline Shea

Inovio Pharmaceuticals

Chief Executive Officer

2023

Laurent Humeau

Inovio Pharmaceuticals

Chief Scientific Officer

News

You may also like